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GA2 i s a n i n b o r n e r r o r o f m e t a b o l i s m c h a r a c t e r i z e d by n o n k e t o t i c hypoglycemia, m e t a b o l i c a c i d o s i s , and e x c r e t i o n o f m e t a b o l i t e s o f f l a v o p r o t e i n d e h y d r o g e n a s e s t h a t t r a n s f e r e l e c t r o n s t o t h e r e s p i r a t o r y c h a i n v i a ETF and ETF DH.
Defects i n t h e s e p r o t e i n s have been proposed t o e x p l a i n t h e d i s c r e p a n c y between t h e a p p a r e n t d e h y d r o g e n a s e d e f i c i e n c i e s i n v i v o and i n whole mutant f i b r o b l a s t s , a n d t h e i r n o r m a l c a t a l y t i c a c t i v i t i e s when asayed i n v i t r o .
A n t i s e r a t o pork l i v e r ETF and ETF D H were r a i s e d i n r a b b i t s ; b o t h c r o s s -r e a c t e d with human mitochondria1 p r o t e i n s o f t h e same molecular weights. Normal human f i b r o b l a s t s produce C W polyp e p t i d e s , a s shown by W e s t e r n b l o t t i n g a n d l o c a l i z a t i o n w i t h p e r o x i d a s e -c o n j u g a t e d a n t i r a b b i t IgG.
Of f o u r GA2 l i n e s examined, two ( u n r e l a t e d p a t i e n t s w i t h n e o n a t a l o n s e t a n d c o n g e n i t a l anomalies) were CRM-f o r ETF D H and CRM+ f o r b o t h ETF s u b u n i t s . The two remaining l i n e s (neonatal o n s e t w/o anomalies) were CRM+ f o r ETF DA; one was d e f i c i e n t i n both ETF s u b u n i t s and t h e o t h e r was d e f i c i e n t o n l y i n t h e a p o l y p e p t i d e .
S t u d y o f l i v e r mitochondria confirmed CRM-f o r ETF D H i n one p a t i e n t , a l s o showing a d e c r e a s e i n t h e c h a r a c t e r i s t i c EPR s i g n a l o f ETF DH, and confirmed CRM-f o r t h e a polypeptide o f ETF i n another.
T h e s e r e s u l t s show t h a t t h e r e is a d e f e c t i n t h i s branch o f t h e r e s p i r a t o r y c h a i n i n GA2, a n d t h a t t h e r e is biochemical and (probably) g e n e t i c h e t e r o g e n e i t y i n t h e c o n d i t i o n . I d i o p a t h i c i n f a n t i l e hypercalcemia i s a r a r e inborn form o f s e v e r e h y p e r s e n s i t i v i t y t o vitamin D which tends t o a b a t e by 1 y e a r of age. We r e p o r t c l i n i c a l s t u d i e s o f a n i n f a n t w i t h t h i s syndrome which b e a r on t h e p a t h o g e n e t i c mechanism. Our p a t i e n t was born a t term t o a d i a b e t i c mother and was t r a n s i e n t l y hypocalcemic i n t h e f i r s t week of l i f e . From 1-3 months, he was i r r i t a b l e and f a i l e d t o t h r i v e on b r e a s t milk (Ca = 31.5 mg/dl) and supplementary vitamin D2 (400 Ufday). At 3 months, hypercalcemia (17.7 mg/dl) was recognized i n a s s o c i a t i o n with depressed serum l e v e l s of PTH ( u n d e t e c t a b l e ) , normal TPR ( 9 0 % ) , 1 , 2 5 dehydroxy-D3 ( 1 1 mg/ml) and 25-hydroxy-D3 ( < 17 ug/ml) and h y p e r c a l c i u r i a (U C a l c r e a t = 1 . 3 ) . P a r e n t s were unaffected and t h e r e was no evidence of nalignancy, subcutaneous f a t n e c r o s i s o r s t i g m a t a of Williams svndrome. Radiologic bone d e n s i t y was i n c r e a s e d and GFR was reduced secondary t o n e p h r o c a l c i n o s i s demonstrable by ultrasound.
Hypercalcemia r e s o l v e d w i t h prednisone therapy ( 1 mglkgfd) and GFR r e t u r n e d t o normal, but growth was poor. On a n o r a l calcium b i n d i n g agent ( c e l l u l o s e phosphate, 0.5 g x 5/d) serum calcium h a s been w e l l c o n t r o l l e d , U C a f c r e a t has decreased t o 0.4 and growth h a s a c c e l e r a t e d . We suggest t h a t hypercalcemia i n t h i s syndrome r e s u l t s from t h e p o s t -n a t a l i n d u c t i o n o f unregulated i n t e s t i n a l vitamin D r e c e p t o r s allowing massive hyperabsorption of d i e t a r y calcium. S t u d i e s o f vitamin D r e c e p t o r s i n t h e p a t i e n t ' s f i b r o b l a s t s a r e i n p r o g r e s s . A n e s t h e t i c a g e n t s can a l t e r h e p a t i c glucuronidation. Under d i e t h y l e t h e r (E), p e n t o b a r b i t a l (P) o r ketamine (K) (n=5 each), r a t s r e c e i v e d b i l e duct and venous c a t h e t e r s . Basal b i l e was c o l l e c t e d f o r 300 min without f u r t h e r a n e s t h e s i a . B i l i r u b i n d iglucuronide (DG) was q u a n t i f i e d by HPLC, t o t a l b i l i r u b i n excret i o n (ugf100 mn body wt/min) by Van den Bergh a n a l y s i s and b i l e flow (pi1100 &I body wtlmin) b$ weight. --------p c . 0 1 NS E a n e s t h e s i a i s a s s o c i a t e d with a r e v e r s i b l e suppression of DG formation and t o t a l b i l i r u b i n e x c r e t i o n . Flow and e x c r e t i o n a r e v a r i a b l e with K. P provided t h e most uniform e x c r e t i o n d a t a . a s mean+SE. VPA inhibited U by 75% and G by 60%. With isolated mitochondria, VPA (20uM) inhibited oxidation of palmityl carnitine, but had no e f f e c t on pyruvate oxidation, suggesting t h a t VPA inhibits a n enzyme(s) of fatty acid oxidation. The inhibition of U and G by VPA may reflect decreased f a t t y acid oxidation with consequent decreased acetyl CoA and NADH or specific inhibition of other enzymes of these pathways. Inhibition of U and G is also consistent with t h e clinical picture seen in VPA toxicity. VPA is more likely t o be toxic under fasting conditions. This model may be useful for the study of ~netabolic a b n~r~n a l i t i e s associated with Reyes Syndrome. W. S a r k s , Giacomo Meschia, and Frederick C.
S i g n i f i-EFFECTS OF VALPROIC ACID (DEPAKENE) ON KETO-GENESIS (K), GLUCONEOGENESIS (G), AND UREA-
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I We have shown previously t h a t f e t a l glucose uptake, u t i l i z at i o n , and o x i d a t i o n r a t e s a r e d i r e c t l y r e l a t e d t o glucose concent r a t i o n [GI. However, [GI and i n s u l i n c o n c e n t r a t i o n [ I ] , a r e a ls o d i r e c t l y r e l a t e d . In o r d e r t o measure t h e s p e c i f i c e f f e c t of
[ I ] independent of [GI on f e t a l glucose u t i l i z a t i o n (GUR) and Conclusions: 2 h r s . o f h v o e r i n s u l i n & n i a a t c o n s t a n t rG1 i n c r e a sed U O U by 10% (p<0.02),"and doubled glucose u t i l i z a t i o n and oxida?ion r a t e s , a1 though t h e f r a c t i o n of glucose oxidized and thus t h e p a r t i t i o n of glucose metabolism was n o t changed.
THIAMINE UPTAKE BY HUMAN FIBROBLASTS. Richard E.
a1 193 Hillman, Barbara Witte, JoAnne C. Kelly, Washington U n i v e r s i t y School of Medicine, S t . Louis C h i l d r e n ' ,~ Hospital, St. Louis.
Thiamine r e q u i r i n g enzymes a r e commonly s t u d i e d i n c u l t u r e d f i b r o b l a s t s but t h e mechanism of thiamine accumulation had n o t been d e f i n e d i n t h e s e c e l l s . Thiamine i s concentrated g r e a t e r than i n t h e medium by 30-60 minutes and reaches apparent c o n c e n t r a t i o n s 6 times t h e medium by 2-3 hours. K i n e t i c s t u d i e s demonstrate t h a t uptake i s s a t u r a b l e and t h e apparent Km(.15-3 pM) and Vmax (.6-.8 p moles/mg/min) a r e s i m i l a r t o t h o s e i n gut and b r a i n . However, t h e uptake p r o c e s s i s q u i t e d i f f e r e n t . Accumulation i s h i g h l y s p e c i f i c b u t n o t energy dependent. Before thiamine i s phosphorylated i t i s bound t o a t l e a s t two <40,000 MI cytoplasmic p r o t e i n s . Uptake and binding a r e c o m p e t i t i v e l y i n h i b i t e d by pyrithiamin but only s l i g h t l y by TP o r TPP. Thiamine e f f l u x i s b i p h a s i c with r a p i d e f f l u x occuring over 30-60 minutes followed by a slow phase l a s t i n g a t l e a s t s e v e r a l hours, probably r e f l e c t i n g phosphorylation.
We conclude t h a t thiamine uptake i n t h e s e c e l l s i s more comparable t o s t e r o i d hormone uptake than t o tbiamine uptake by s p e c i a l i z e d t r a n s p o r t t i s s u e .
